South Africa’s drugs regulator to start assessing Sinovac COVID-19 vaccine

A health care worker wearing a protective mask and a face shield prepares a dose of China’s Sinovac Biotech vaccine for the coronavirus disease (COVID-19) at a drive-thru vaccination station, during the mass vaccination program for elderly people, in Jakarta, Indonesia, March 5, 2021. REUTERS/Willy Kurniawan

JOHANNESBURG (Reuters) – South Africa’s medicines regulator SAHPRA said on Friday that it had received documentation for the COVID-19 vaccine developed by China’s Sinovac.

It added in a statement that it would now start evaluating the data and assessing the efficacy of the vaccine.

Reporting by Alexander Winning; Editing by Christopher Cushing

source: reuters.com